Mechanisms and management of multimorbidity in patients with COPD
Multimorbidity, defined as the presence of two or more chronic conditions, represents a significant challenge in the management of COPD, a complex and highly prevalent disease. The coexistence of chronic conditions such as cardiovascular or metabolic diseases increases the frequency and severity of COPD exacerbations, complicates treatment decisions and worsens patient outcomes. These coexisting diseases may share underlying mechanisms, including systemic inflammation, oxidative stress and risk factors such as smoking, which accelerate disease progression. In this review, we discuss the prevalence and clinical significance of multimorbidity in COPD, with a focus on shared risk factors, the pathophysiological mechanisms and the impact on outcomes. Additionally, we examine current disease management strategies for COPD and multimorbidity, highlighting the need for a multidisciplinary, personalised approach, and discuss the role of biomarkers in coexisting conditions.
Authors
- Vijay K. T. Alagappan
- Stephanie A. Christenson (ORCID: https://orcid.org/0000-0003-1550-2815)
- Gerard J. Criner (ORCID: https://orcid.org/0000-0003-1267-3483)
- Claus Franz Vogelmeier (ORCID: https://orcid.org/0000-0002-9798-2527)
- Jigna Heble
- Fuqiang Wen (ORCID: https://orcid.org/0000-0001-6205-4758)
Institutions
- University of California, San Francisco (US)
- Sichuan University (CN)
- Morristown Medical Center (US)
- West China Hospital of Sichuan University (CN)
- Progenics Pharmaceuticals (United States) (US)
- German Center for Lung Research (DE)
- C3I (United States) (US)
- Temple University (US)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1183/13993003.02435-2025
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00